{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:21:44Z","timestamp":1792448504030,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The hallmarks of systemic sclerosis (SSc) are autoimmunity, microangiopathy and fibrosis. Skin fibrosis is accompanied by attrition of the dermal white adipose tissue layer, and alterations in the levels and function of adiponectin. Since these findings potentially implicate adiponectin in the pathogenesis of SSc, we employed a novel pharmacological approach to augment adiponectin signaling using AdipoRon, an orally active adiponectin receptor agonist. Chronic treatment with AdipoRon significantly ameliorated bleomycin-induced dermal fibrosis in mice. AdipoRon attenuated fibroblast activation, adipocyte-to-myofibroblast transdifferentiation, Th2\/Th17-skewed polarization of the immune response, vascular injury and endothelial-to-mesenchymal transition within the lesional skin. <jats:italic>In vitro<\/jats:italic>, AdipoRon abrogated profibrotic responses elicited by TGF-\u03b2 in normal fibroblasts, and reversed the inherently-activated profibrotic phenotype of SSc fibroblasts. In view of these broadly beneficial effects on all three cardinal pathomechanisms underlying the clinical manifestations of SSc, pharmacological augmentation of adiponectin signaling might represent a novel strategy for the treatment of SSc.<\/jats:p>","DOI":"10.1038\/s41598-018-29901-w","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T14:22:05Z","timestamp":1533133325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Takashi","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Lakota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snezn","family":"Sodin-Semrl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-9778","authenticated-orcid":false,"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"key":"29901_CR1","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nat Rev Dis Primers 1, 15002, https:\/\/doi.org\/10.1038\/nrdp.2015.2 (2015).","journal-title":"Nat Rev Dis Primers"},{"key":"29901_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2741\/s22","volume":"1","author":"J Varga","year":"2009","unstructured":"Varga, J. & Whitfield, M. L. Transforming growth factor-b in systemic sclerosis (scleroderma). Frontiers in bioscience 1, 226\u2013235 (2009).","journal-title":"Frontiers in bioscience"},{"key":"29901_CR3","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli, A., Avvedimento, E. V. & Krieg, T. Scleroderma. N Engl J Med 360, 1989\u20132003, https:\/\/doi.org\/10.1056\/NEJMra0806188 (2009).","journal-title":"N Engl J Med"},{"key":"29901_CR4","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1186\/ar3827","volume":"14","author":"K Lakota","year":"2012","unstructured":"Lakota, K. et al. Levels of adiponectin, a marker for PPAR-g activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? Arthritis Res Ther 14, R102, https:\/\/doi.org\/10.1186\/ar3827 (2012).","journal-title":"Arthritis Res Ther"},{"key":"29901_CR5","doi-asserted-by":"publisher","first-page":"R229","DOI":"10.1186\/ar4070","volume":"14","author":"F Fang","year":"2012","unstructured":"Fang, F. et al. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy. Arthritis Res Ther 14, R229, https:\/\/doi.org\/10.1186\/ar4070 (2012).","journal-title":"Arthritis Res Ther"},{"key":"29901_CR6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/art.38990","volume":"67","author":"RG Marangoni","year":"2015","unstructured":"Marangoni, R. G. et al. Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors. Arthritis Rheumatol 67, 1062\u20131073, https:\/\/doi.org\/10.1002\/art.38990 (2015).","journal-title":"Arthritis Rheumatol"},{"key":"29901_CR7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1600-0625.2011.01310.x","volume":"20","author":"H Arakawa","year":"2011","unstructured":"Arakawa, H. et al. Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients. Exp Dermatol 20, 764\u2013766, https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01310.x (2011).","journal-title":"Exp Dermatol"},{"key":"29901_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya, S., Wei, J. & Varga, J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 8, 42\u201354, https:\/\/doi.org\/10.1038\/nrrheum.2011.149 (2012).","journal-title":"Nat Rev Rheumatol"},{"key":"29901_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11926-017-0627-y","volume":"19","author":"IL Kruglikov","year":"2017","unstructured":"Kruglikov, I. L. Interfacial Adipose Tissue in Systemic Sclerosis. Curr Rheumatol Rep 19, 4, https:\/\/doi.org\/10.1007\/s11926-017-0627-y (2017).","journal-title":"Curr Rheumatol Rep"},{"key":"29901_CR10","doi-asserted-by":"crossref","unstructured":"Matsuzawa, Y., Shimomura, I., Kihara, S. & Funahashi, T. Importance of adipocytokines in obesity-related diseases. Horm Res 60 Suppl 3, 56\u201359, 74502 (2003).","DOI":"10.1159\/000074502"},{"key":"29901_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1468-3083.2011.04077.x","volume":"26","author":"Y Masui","year":"2012","unstructured":"Masui, Y. et al. Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis. J Eur Acad Dermatol Venereol 26, 354\u2013360, https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04077.x (2012).","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"29901_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/s10165-012-0660-7","volume":"23","author":"Y Masui","year":"2013","unstructured":"Masui, Y. et al. Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis. Mod Rheumatol 23, 323\u2013329, https:\/\/doi.org\/10.1007\/s10165-012-0660-7 (2013).","journal-title":"Mod Rheumatol"},{"key":"29901_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/rheumatology\/ket010","volume":"52","author":"Y Masui","year":"2013","unstructured":"Masui, Y. et al. A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response. Rheumatology (Oxford) 52, 1239\u20131244, https:\/\/doi.org\/10.1093\/rheumatology\/ket010 (2013).","journal-title":"Rheumatology (Oxford)"},{"key":"29901_CR14","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00296-013-2880-3","volume":"34","author":"Y Masui","year":"2014","unstructured":"Masui, Y. et al. Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis. Rheumatol Int 34, 1165\u20131170, https:\/\/doi.org\/10.1007\/s00296-013-2880-3 (2014).","journal-title":"Rheumatol Int"},{"key":"29901_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1468-3083.2011.04413.x","volume":"27","author":"T Toyama","year":"2013","unstructured":"Toyama, T. et al. Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis. J Eur Acad Dermatol Venereol 27, 337\u2013344, https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04413.x (2013).","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"29901_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1468-3083.2011.04354.x","volume":"27","author":"N Aozasa","year":"2013","unstructured":"Aozasa, N. et al. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis. J Eur Acad Dermatol Venereol 27, 37\u201342, https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04354.x (2013).","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"29901_CR17","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bjd.13779","volume":"173","author":"T Takahashi","year":"2015","unstructured":"Takahashi, T. et al. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis. Br J Dermatol 173, 681\u2013689, https:\/\/doi.org\/10.1111\/bjd.13779 (2015).","journal-title":"Br J Dermatol"},{"key":"29901_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/1346-8138.12824","volume":"42","author":"S Miura","year":"2015","unstructured":"Miura, S. et al. Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis. J Dermatol 42, 461\u2013466, https:\/\/doi.org\/10.1111\/1346-8138.12824 (2015).","journal-title":"J Dermatol"},{"key":"29901_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/1346-8138.12810","volume":"42","author":"S Miura","year":"2015","unstructured":"Miura, S. et al. Serum vaspin levels: A possible correlation with digital ulcers in patients with systemic sclerosis. J Dermatol 42, 528\u2013531, https:\/\/doi.org\/10.1111\/1346-8138.12810 (2015).","journal-title":"J Dermatol"},{"key":"29901_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cyto.2012.02.003","volume":"58","author":"M Tomcik","year":"2012","unstructured":"Tomcik, M. et al. Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis. Cytokine 58, 165\u2013168, https:\/\/doi.org\/10.1016\/j.cyto.2012.02.003 (2012).","journal-title":"Cytokine"},{"key":"29901_CR21","doi-asserted-by":"publisher","first-page":"D561","DOI":"10.1093\/nar\/gks1114","volume":"41","author":"C Wu","year":"2013","unstructured":"Wu, C., Macleod, I. & Su, A. I. BioGPS and MyGene.info: organizing online, gene-centric information. Nucleic Acids Res 41, D561\u2013565, https:\/\/doi.org\/10.1093\/nar\/gks1114 (2013).","journal-title":"Nucleic Acids Res"},{"key":"29901_CR22","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1073\/pnas.0400782101","volume":"101","author":"AI Su","year":"2004","unstructured":"Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101, 6062\u20136067, https:\/\/doi.org\/10.1073\/pnas.0400782101 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"29901_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/0961203309103582","volume":"18","author":"C Chung","year":"2009","unstructured":"Chung, C. et al. Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus 18, 799\u2013806, https:\/\/doi.org\/10.1177\/0961203309103582 (2009).","journal-title":"Lupus"},{"key":"29901_CR24","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/art.24626","volume":"60","author":"YH Rho","year":"2009","unstructured":"Rho, Y. H. et al. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 60, 1906\u20131914, https:\/\/doi.org\/10.1002\/art.24626 (2009).","journal-title":"Arthritis Rheum"},{"key":"29901_CR25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jaci.2007.10.018","volume":"121","author":"G Fantuzzi","year":"2008","unstructured":"Fantuzzi, G. Adiponectin and inflammation: Consensus and controversy. J Allergy Clin Immunol 121, 326\u2013330, https:\/\/doi.org\/10.1016\/j.jaci.2007.10.018 (2008).","journal-title":"J Allergy Clin Immunol"},{"key":"29901_CR26","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1053\/j.gastro.2003.08.029","volume":"125","author":"Y Kamada","year":"2003","unstructured":"Kamada, Y. et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125, 1796\u20131807 (2003).","journal-title":"Gastroenterology"},{"key":"29901_CR27","doi-asserted-by":"publisher","first-page":"e0125169","DOI":"10.1371\/journal.pone.0125169","volume":"10","author":"R Yao","year":"2015","unstructured":"Yao, R. et al. Adiponectin attenuates lung fibroblasts activation and pulmonary fibrosis induced by paraquat. PLoS One 10, e0125169, https:\/\/doi.org\/10.1371\/journal.pone.0125169 (2015).","journal-title":"PLoS One"},{"key":"29901_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/ATVBAHA.107.156687","volume":"28","author":"K Fujita","year":"2008","unstructured":"Fujita, K. et al. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-\u03b1. Arterioscler Thromb Vasc Biol 28, 863\u2013870, https:\/\/doi.org\/10.1161\/ATVBAHA.107.156687 (2008).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"29901_CR29","doi-asserted-by":"publisher","first-page":"e110405","DOI":"10.1371\/journal.pone.0110405","volume":"9","author":"P Kumar","year":"2014","unstructured":"Kumar, P., Smith, T., Rahman, K., Thorn, N. E. & Anania, F. A. Adiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in mice. PLoS One 9, e110405, https:\/\/doi.org\/10.1371\/journal.pone.0110405 (2014).","journal-title":"PLoS One"},{"key":"29901_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature12656","volume":"503","author":"M Okada-Iwabu","year":"2013","unstructured":"Okada-Iwabu, M. et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503, 493\u2013499, https:\/\/doi.org\/10.1038\/nature12656 (2013).","journal-title":"Nature"},{"key":"29901_CR31","doi-asserted-by":"publisher","first-page":"E275","DOI":"10.1152\/ajpendo.00577.2014","volume":"309","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings. Am J Physiol Endocrinol Metab 309, E275\u2013282, https:\/\/doi.org\/10.1152\/ajpendo.00577.2014 (2015).","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"29901_CR32","doi-asserted-by":"publisher","unstructured":"Hong, K. et al. Adiponectin Receptor Agonist, AdipoRon, Causes Vasorelaxation Predominantly Via a Direct Smooth Muscle Action. Microcirculation https:\/\/doi.org\/10.1111\/micc.12266 (2016).","DOI":"10.1111\/micc.12266"},{"key":"29901_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/jcp.20251","volume":"203","author":"S Chujo","year":"2005","unstructured":"Chujo, S. et al. Connective tissue growth factor causes persistent proa2(I) collagen gene expression induced by transforming growth factor-b in a mouse fibrosis model. J Cell Physiol 203, 447\u2013456, https:\/\/doi.org\/10.1002\/jcp.20251 (2005).","journal-title":"J Cell Physiol"},{"key":"29901_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.exphem.2013.12.009","volume":"42","author":"H Nakasone","year":"2014","unstructured":"Nakasone, H. et al. Impact of high-\/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts. Exp Hematol 42, 261\u2013273, https:\/\/doi.org\/10.1016\/j.exphem.2013.12.009 (2014).","journal-title":"Exp Hematol"},{"key":"29901_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2011.09.151","volume":"415","author":"T Yamane","year":"2011","unstructured":"Yamane, T., Kobayashi-Hattori, K. & Oishi, Y. Adiponectin promotes hyaluronan synthesis along with increases in hyaluronan synthase 2 transcripts through an AMP-activated protein kinase\/peroxisome proliferator-activated receptor-a-dependent pathway in human dermal fibroblasts. Biochem Biophys Res Commun 415, 235\u2013238, https:\/\/doi.org\/10.1016\/j.bbrc.2011.09.151 (2011).","journal-title":"Biochem Biophys Res Commun"},{"key":"29901_CR36","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3109\/s10165-012-0813-8","volume":"23","author":"S Yukawa","year":"2013","unstructured":"Yukawa, S. et al. Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis. Mod Rheumatol 23, 1151\u20131157, https:\/\/doi.org\/10.1007\/s10165-012-0813-8 (2013).","journal-title":"Mod Rheumatol"},{"key":"29901_CR37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/art.30190","volume":"63","author":"T H\u00fcgle","year":"2011","unstructured":"H\u00fcgle, T., Hogan, V., White, K. E. & van Laar, J. M. Mast cells are a source of transforming growth factor \u03b2 in systemic sclerosis. Arthritis Rheum 63, 795\u2013799, https:\/\/doi.org\/10.1002\/art.30190 (2011).","journal-title":"Arthritis Rheum"},{"key":"29901_CR38","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1186\/ar3066","volume":"12","author":"N Higashi-Kuwata","year":"2010","unstructured":"Higashi-Kuwata, N. et al. Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther 12, R128, https:\/\/doi.org\/10.1186\/ar3066 (2010).","journal-title":"Arthritis Res Ther"},{"key":"29901_CR39","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","volume":"185","author":"A Yoshizaki","year":"2010","unstructured":"Yoshizaki, A. et al. Cell adhesion molecules regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol 185, 2502\u20132515, https:\/\/doi.org\/10.4049\/jimmunol.0901778 (2010).","journal-title":"J Immunol"},{"key":"29901_CR40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/art.38948","volume":"67","author":"T Taniguchi","year":"2015","unstructured":"Taniguchi, T. et al. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice. Arthritis Rheumatol 67, 517\u2013526, https:\/\/doi.org\/10.1002\/art.38948 (2015).","journal-title":"Arthritis Rheumatol"},{"key":"29901_CR41","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","volume":"179","author":"S Piera-Velazquez","year":"2011","unstructured":"Piera-Velazquez, S., Li, Z. & Jimenez, S. A. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 179, 1074\u20131080, https:\/\/doi.org\/10.1016\/j.ajpath.2011.06.001 (2011).","journal-title":"Am J Pathol"},{"key":"29901_CR42","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1002\/art.30316","volume":"63","author":"M Manetti","year":"2011","unstructured":"Manetti, M., Guiducci, S. & Matucci-Cerinic, M. The origin of the myofibroblast in fibroproliferative vasculopathy: does the endothelial cell steer the pathophysiology of systemic sclerosis? Arthritis Rheum 63, 2164\u20132167, https:\/\/doi.org\/10.1002\/art.30316 (2011).","journal-title":"Arthritis Rheum"},{"key":"29901_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.matbio.2016.01.012","volume":"51","author":"SA Jimenez","year":"2016","unstructured":"Jimenez, S. A. & Piera-Velazquez, S. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality? Matrix Biol 51, 26\u201336, https:\/\/doi.org\/10.1016\/j.matbio.2016.01.012 (2016).","journal-title":"Matrix Biol"},{"key":"29901_CR44","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","volume":"76","author":"M Manetti","year":"2017","unstructured":"Manetti, M. et al. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Ann Rheum Dis 76, 924\u2013934, https:\/\/doi.org\/10.1136\/annrheumdis-2016-210229 (2017).","journal-title":"Ann Rheum Dis"},{"key":"29901_CR45","doi-asserted-by":"publisher","first-page":"15136","DOI":"10.1073\/pnas.1520997112","volume":"112","author":"R Saigusa","year":"2015","unstructured":"Saigusa, R. et al. Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis. Proc Natl Acad Sci USA 112, 15136\u201315141, https:\/\/doi.org\/10.1073\/pnas.1520997112 (2015).","journal-title":"Proc Natl Acad Sci USA"},{"key":"29901_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jid.2015.10.058","volume":"136","author":"T Toyama","year":"2016","unstructured":"Toyama, T. et al. Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells. J Invest Dermatol 136, 387\u2013398, https:\/\/doi.org\/10.1016\/j.jid.2015.10.058 (2016).","journal-title":"J Invest Dermatol"},{"key":"29901_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/art.39421","volume":"68","author":"FA Mendoza","year":"2016","unstructured":"Mendoza, F. A., Piera-Velazquez, S., Farber, J. L., Feghali-Bostwick, C. & Jimenez, S. A. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease. Arthritis Rheumatol 68, 210\u2013217, https:\/\/doi.org\/10.1002\/art.39421 (2016).","journal-title":"Arthritis Rheumatol"},{"key":"29901_CR48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1600-0560.2006.00584.x","volume":"34","author":"V Chaudhuri","year":"2007","unstructured":"Chaudhuri, V., Zhou, L. & Karasek, M. Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis. J Cutan Pathol 34, 146\u2013153, https:\/\/doi.org\/10.1111\/j.1600-0560.2006.00584.x (2007).","journal-title":"J Cutan Pathol"},{"key":"29901_CR49","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu, V. S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19, 1047\u20131053, https:\/\/doi.org\/10.1038\/nm.3218 (2013).","journal-title":"Nat Med"},{"key":"29901_CR50","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1152\/ajplung.00378.2006","volume":"293","author":"E Arciniegas","year":"2007","unstructured":"Arciniegas, E., Frid, M. G., Douglas, I. S. & Stenmark, K. R. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 293, L1\u20138, https:\/\/doi.org\/10.1152\/ajplung.00378.2006 (2007).","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"29901_CR51","doi-asserted-by":"publisher","first-page":"C550","DOI":"10.1152\/ajpcell.00123.2010","volume":"300","author":"H Xu","year":"2011","unstructured":"Xu, H. et al. Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis. Am J Physiol Cell Physiol 300, C550\u2013556, https:\/\/doi.org\/10.1152\/ajpcell.00123.2010 (2011).","journal-title":"Am J Physiol Cell Physiol"},{"key":"29901_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep11296","volume":"5","author":"X Sun","year":"2015","unstructured":"Sun, X. et al. Adiponectin exacerbates collagen-induced arthritis via enhancing Th17 response and prompting RANKL expression. Sci Rep 5, 11296, https:\/\/doi.org\/10.1038\/srep11296 (2015).","journal-title":"Sci Rep"},{"key":"29901_CR53","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00408-015-9793-8","volume":"193","author":"R de Lima Azambuja","year":"2015","unstructured":"de Lima Azambuja, R., da Costa Santos Azambuja, L. S., Costa, C. & Rufino, R. Adiponectin in Asthma and Obesity: Protective Agent or Risk Factor for More Severe Disease? Lung 193, 749\u2013755, https:\/\/doi.org\/10.1007\/s00408-015-9793-8 (2015).","journal-title":"Lung"},{"key":"29901_CR54","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1002\/art.34643","volume":"64","author":"Y Okamoto","year":"2012","unstructured":"Okamoto, Y. et al. Potential roles of interleukin-17A in the development of skin fibrosis in mice. Arthritis Rheum 64, 3726\u20133735, https:\/\/doi.org\/10.1002\/art.34643 (2012).","journal-title":"Arthritis Rheum"},{"key":"29901_CR55","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","volume":"135","author":"KG MacDonald","year":"2015","unstructured":"MacDonald, K. G. et al. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis. J Allergy Clin Immunol 135, 946\u2013e949, https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1932 (2015).","journal-title":"J Allergy Clin Immunol"},{"key":"29901_CR56","first-page":"275","volume":"33","author":"T Matsushita","year":"2006","unstructured":"Matsushita, T., Hasegawa, M., Hamaguchi, Y., Takehara, K. & Sato, S. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol 33, 275\u2013284 (2006).","journal-title":"J Rheumatol"},{"key":"29901_CR57","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","volume":"50","author":"M Murata","year":"2008","unstructured":"Murata, M. et al. Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? J Dermatol Sci 50, 240\u2013242, https:\/\/doi.org\/10.1016\/j.jdermsci.2008.01.001 (2008).","journal-title":"J Dermatol Sci"},{"key":"29901_CR58","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","volume":"37","author":"Y Asano","year":"2015","unstructured":"Asano, Y. & Sato, S. Vasculopathy in scleroderma. Semin Immunopathol 37, 489\u2013500, https:\/\/doi.org\/10.1007\/s00281-015-0505-5 (2015).","journal-title":"Semin Immunopathol"},{"key":"29901_CR59","doi-asserted-by":"publisher","first-page":"e88150","DOI":"10.1371\/journal.pone.0088150","volume":"9","author":"M Hasegawa","year":"2014","unstructured":"Hasegawa, M. et al. Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. PLoS One 9, e88150, https:\/\/doi.org\/10.1371\/journal.pone.0088150 (2014).","journal-title":"PLoS One"},{"key":"29901_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-2007-978586","volume":"32","author":"Y Okamoto","year":"2000","unstructured":"Okamoto, Y. et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 32, 47\u201350, https:\/\/doi.org\/10.1055\/s-2007-978586 (2000).","journal-title":"Horm Metab Res"},{"key":"29901_CR61","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1021\/bi9006258","volume":"48","author":"BR Kupchak","year":"2009","unstructured":"Kupchak, B. R., Garitaonandia, I., Villa, N. Y., Smith, J. L. & Lyons, T. J. Antagonism of human adiponectin receptors and their membrane progesterone receptor paralogs by TNFa and a ceramidase inhibitor. Biochemistry 48, 5504\u20135506, https:\/\/doi.org\/10.1021\/bi9006258 (2009).","journal-title":"Biochemistry"},{"key":"29901_CR62","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1074\/jbc.M112.404624","volume":"288","author":"F Almabouada","year":"2013","unstructured":"Almabouada, F. et al. Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties. J Biol Chem 288, 3112\u20133125, https:\/\/doi.org\/10.1074\/jbc.M112.404624 (2013).","journal-title":"J Biol Chem"},{"key":"29901_CR63","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nature14301","volume":"520","author":"H Tanabe","year":"2015","unstructured":"Tanabe, H. et al. Crystal structures of the human adiponectin receptors. Nature 520, 312\u2013316, https:\/\/doi.org\/10.1038\/nature14301 (2015).","journal-title":"Nature"},{"key":"29901_CR64","doi-asserted-by":"publisher","first-page":"658913","DOI":"10.1155\/2014\/658913","volume":"2014","author":"E Nigro","year":"2014","unstructured":"Nigro, E. et al. New insight into adiponectin role in obesity and obesity-related diseases. BioMed Research International 2014, 658913, https:\/\/doi.org\/10.1155\/2014\/658913 (2014).","journal-title":"BioMed Research International"},{"key":"29901_CR65","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/ejcn.2013.197","volume":"67","author":"B Gray","year":"2013","unstructured":"Gray, B., Steyn, F., Davies, P. S. & Vitetta, L. Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. Eur J Clin Nutr 67, 1234\u20131242, https:\/\/doi.org\/10.1038\/ejcn.2013.197 (2013).","journal-title":"Eur J Clin Nutr"},{"key":"29901_CR66","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fpls.2015.00163","volume":"6","author":"S Anil Kumar","year":"2015","unstructured":"Anil Kumar, S., Hima Kumari, P., Shravan Kumar, G., Mohanalatha, C. & Kavi Kishor, P. B. Osmotin: a plant sentinel and a possible agonist of mammalian adiponectin. Front Plant Sci 6, 163, https:\/\/doi.org\/10.3389\/fpls.2015.00163 (2015).","journal-title":"Front Plant Sci"},{"key":"29901_CR67","doi-asserted-by":"publisher","first-page":"e63354","DOI":"10.1371\/journal.pone.0063354","volume":"8","author":"Y Sun","year":"2013","unstructured":"Sun, Y. et al. Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay. PLoS One 8, e63354, https:\/\/doi.org\/10.1371\/journal.pone.0063354 (2013).","journal-title":"PLoS One"},{"key":"29901_CR68","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1126\/science.1249077","volume":"342","author":"WL Holland","year":"2013","unstructured":"Holland, W. L. & Scherer, P. E. Cell Biology. Ronning after the adiponectin receptors. Science 342, 1460\u20131461, https:\/\/doi.org\/10.1126\/science.1249077 (2013).","journal-title":"Science"},{"key":"29901_CR69","doi-asserted-by":"publisher","first-page":"R86","DOI":"10.1186\/ar4529","volume":"16","author":"K Akamata","year":"2014","unstructured":"Akamata, K. et al. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1. Arthritis Res Ther 16, R86, https:\/\/doi.org\/10.1186\/ar4529 (2014).","journal-title":"Arthritis Res Ther"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29901-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29901-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29901-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:11:28Z","timestamp":1671610288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29901-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29901"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29901-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,7]]},"assertion":[{"value":"17 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11843"}}